Laos FDD Medical Device Registration and Notification: Class A–D Guide

Quick answer

Laos regulates medical devices through the Food and Drug Department (FDD) of the Ministry of Health (MOH), under the Law on Medicines and Medical Products and Decision No. 1470/MOH (11 July 2023) on the Registration and Notification of Medical Devices. Class A devices require notification to FDD using Form MD.2; Class B, C, and D devices require registration using Form MD.1. FDD review timelines are approximately 15 working days for low-risk or reliance-based cases, 30 working days for Class B, and 60 working days for Class C and D. Approved registration certificates are valid for five years; renewals use Form MD.3 and should be submitted roughly 90 working days before expiry. MOH phased implementation from 1 January 2024 (Class C and D) through 1 January 2025 (Class A notification and Class B registration). Official information and the English law text are published at fdd.gov.la.

Who this applies to

This guide applies to:

• Domestic manufacturers placing medical devices on the Lao market
• Importers bringing medical devices into Lao PDR for distribution
• Local authorized representatives acting on behalf of foreign manufacturers
• Regulatory affairs teams mapping ASEAN AMDD classes to Laos FDD requirements

Device scope covers Class A, B, C, and D medical devices as defined in the Law on Medicines and Medical Products (Articles 28–33). In vitro diagnostics, medicines, and non-device health products fall outside Decision 1470 and are governed by separate FDD procedures.

Applicants must typically be a locally incorporated importer or domestic manufacturer with a valid business registration in Lao PDR. Foreign manufacturers without a local entity cannot submit directly; they appoint a local partner to hold the registration or notification certificate.

Legal framework: Law on Medicines and Medical Products and Decision 1470/MOH

The Law on Medicines and Medical Products (English version published on the FDD website) establishes that medical devices are classified A–D by risk and that manufacturers and importers must obtain MOH authorization before supply. Article 53 requires registration or notification procedures to be set out in separate regulations.

Decision No. 1470/MOH (Registration and Notification of Medical Devices, signed 11 July 2023) is the implementing regulation that operationalizes Article 53. It defines:

• Which device classes require notification versus registration
• Official application forms MD.1 through MD.4
• FDD review timelines by class and pathway
• Certificate validity and renewal obligations
• Phased effective dates for class-by-class enforcement
• Administrative penalties for non-compliance

The Lao Trade Portal confirms that drugs and medical products must be registered before import for distribution—a requirement that aligns with FDD market-access controls under the medicines law.

Official resource: https://fdd.gov.la/

Class A notification vs Class B–D registration

Decision 1470 draws a clear line between low-risk notification and higher-risk registration. The table below summarizes the primary obligations.

Class A notification is not a full registration review. FDD accepts the notification dossier, verifies completeness, and records the device. Notification still creates a legal obligation: the device may not be supplied without FDD acknowledgment.

Class B, C, and D registration requires substantive FDD evaluation. Class C and D dossiers must follow the ASEAN Common Submission Dossier Template (CSDT) format per FDD implementation materials referenced in MOH communications. Class B submissions require a reduced technical file proportionate to risk, but still exceed Class A notification content.

Official forms MD.1–MD.4

Decision 1470 assigns four standardized forms, referenced in the AHWP Laos annex and FDD implementation guidance:

Each form must be completed in the format prescribed by MOH, accompanied by supporting technical documentation, proof of local applicant status, and applicable fees. Incomplete submissions restart the review clock.

FDD review timelines: 15, 30, and 60 working days

Decision 1470 sets target review periods counted in working days from receipt of a complete application:

• ~15 working days — Class A notification and other low-risk pathways, including cases where FDD accepts reliance on prior approval from recognized reference regulatory authorities
• ~30 working days — Class B registration applications
• ~60 working days — Class C and D registration applications requiring full CSDT evaluation

These timelines apply only when the dossier is complete and accepted for review. FDD may issue deficiency letters; the clock pauses until the applicant responds. Plan buffer time for translation, notarization, and local incorporation steps before counting review days.

Certificate validity and renewal: five years

Registration certificates issued under Decision 1470 are valid for five years from the date of issuance. Notification records for Class A devices are similarly subject to periodic update requirements when device attributes change.

Renewal uses Form MD.3. MOH guidance recommends submitting renewal applications approximately 90 working days before certificate expiry to avoid a supply gap. Late renewal may require treating the device as a new registration if the certificate lapses.

Renewal dossiers typically include:

• Updated MD.3 application form
• Current registration certificate copy
• Post-market surveillance summary (for Class C and D)
• Evidence of continued conformity (ISO 13485, audit reports, or reference-agency listing updates)
• Updated labeling and IFU if changed since initial approval

Variations during the five-year term—not full renewals—are submitted on Form MD.4.

Phased rollout: 2024–2025 implementation schedule

MOH implemented Decision 1470 in phases to allow industry transition. Per MOH implementation communications cited in the AHWP Laos annex:

Implications for market access planning:

• Devices in Classes C and D required valid FDD registration before lawful supply from 2024 onward
• Class A and B obligations became enforceable from 2025; legacy unregistered stock should have been cleared or regularized
• Importers relying on pre-2024 informal supply channels must now hold current FDD authorization

Always confirm the latest FDD circulars at fdd.gov.la before assuming transition grace periods still apply.

Step-by-step workflow

1. Confirm device classification under AMDD-aligned rules in the Law on Medicines and Medical Products (Articles 28–33).
2. Establish local applicant entity — incorporated importer or domestic manufacturer in Lao PDR.
3. Appoint foreign manufacturer liaison if the legal manufacturer is overseas; gather ISO 13485 and reference approvals.
4. Select pathway:
   • Class A → prepare MD.2 notification dossier
   • Class B/C/D → prepare MD.1 registration dossier (CSDT for C and D)
5. Compile technical documentation — labeling in Lao or approved language, IFU, risk classification rationale, clinical evaluation (Class C/D), and proof of QMS.
6. Submit application to FDD at MOH with prescribed fees.
7. Respond to deficiency letters within FDD deadlines to keep review timelines active.
8. Receive certificate or notification acknowledgment — verify device name, model, and applicant details match import documentation.
9. Register on Lao Trade Portal import procedures if required for customs clearance.
10. Maintain post-market obligations — adverse event reporting, variation submissions (MD.4), and renewal (MD.3) before expiry.

Key documents and what they must contain

MD.1 registration dossier (Class B, C, D)

• Completed MD.1 application form with device nomenclature and classification
• Legal manufacturer and local applicant details
• Executive summary and device description
• Essential principles checklist / conformity declaration
• Labeling and instructions for use
• Risk management file summary
• Clinical evaluation or clinical evidence (Class C and D; proportionate for Class B)
• CSDT modules for Class C and D (device description, design verification, sterilization, biocompatibility as applicable)
• Free Sale Certificate or reference-agency approval (for reliance pathways)
• Proof of ISO 13485 or equivalent QMS

MD.2 notification dossier (Class A)

• Completed MD.2 form
• Device description and intended use
• Classification rationale confirming Class A
• Labeling sample
• Manufacturer details and local applicant authorization letter

MD.3 renewal package

• MD.3 form referencing existing certificate number
• Updated PMS data for higher-risk classes
• Confirm...